[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100512295":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":16,"locations":23,"responsibleParty":42,"collaborators":7,"id":44,"slug":7,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":7,"eligibilityCriteria":49,"healthyVolunteers":45,"sex":50,"minAge":51,"maxAge":52,"enrollmentInfo":53,"targetDuration":7,"studyType":56,"phases":57,"briefSummary":59,"conditions":60,"keywords":7,"overallStatus":26,"whyStopped":7,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":71},{"fullName":5,"class":6},"University Health Network, Toronto","OTHER",null,[9,13],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"RADIATION","Radiotherapy","Standard of care pre-operative radiotherapy",{"type":6,"name":14,"description":15,"armGroupLabels":7,"otherNames":7},"Surgery","Standard of care definitive surgery",[17],{"name":18,"role":19,"phone":20,"phoneExt":21,"email":22},"David Shultz, MD","CONTACT","416-946-4501","2121","david.shultz@rmp.uhn.ca",[24],{"facility":25,"status":26,"city":27,"state":28,"zip":29,"country":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"University Health Network","RECRUITING","Toronto","Ontario","L4W4C2","Canada",{"type":32,"coordinates":33},"Point",[34,35],-79.39864,43.70643,{"lat":35,"lon":34},[38],{"name":18,"role":19,"phone":39,"phoneExt":40,"email":41},"416 946 4501","6899","david.shultz@uhn.ca",{"type":43,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100512295",false,"NCT05950594","IVIM & OLINK in Sarcoma","Prospective Study of Image and Blood-derived Biomarkers to Predict Metastasis in Soft-tissue Sarcomas","Inclusion Criteria:\n\n* Age ≥ 18 years\n* Ability to understand and the willingness to sign a written informed consent document\n* Grade 2 or 3 soft tissue sarcoma greater than 5 cm in largest dimension\n\nExclusion Criteria:\n\n* Contraindication to MRI scan as per current institutional guidelines (for patients requiring MRI)","ALL","18 Years","100 Years",{"count":54,"type":55},145,"ESTIMATED","INTERVENTIONAL",[58],"PHASE2","The hypoxia \\> metastasis axis suggests that a DWI-based biomarker of hypoxia incorporating IVIM may be able to predict metastasis in STS patients, ultimately enabling stratification for personalized treatments at the time of diagnostic (MR) imaging, without adding an excessive burden to the patient or clinical workflow (typical DWI\u002FIVIM sequences can be acquired acquired in approximately 5 minutes).",[61],"Soft Tissue Sarcoma","2026-03-11",{"date":64,"type":65},"2026-03-16","ACTUAL",{"date":67,"type":65},"2024-03-05",{"date":69,"type":55},"2027-11-30",{"name":5,"class":6},1]